Abstract:BACKGROUND: Three types of characteristic ST-segment elevation are associated with Brugada syndrome but only type 1 is diagnostic. Why only type 1 ECG is diagnostic remains unanswered. METHODS: Computer simulations were performed in single cells, 1-dimensional cables, and 2-dimensional tissues to investigate the effects of the peak and late components of the transient outward potassium current (I-to), sodium current, and L-type calcium current (I-ca,I-L) as well as other potassium currents on the genesis of ECG morphologies and phase 2 reentry (P2R). RESULTS: Although a sufficiently large peak I-to was required to result in the type 1 ECG pattern and P2R, increasing the late component of I-to converted type 1 ECG to type 2 ECG and suppressed P2R. Increasing the peak I-to promoted spiral wave breakup, potentiating the transition from tachycardia to fibrillation, but increasing the late I-to prevented spiral wave breakup by flattening the action potential duration restitution and preventing P2R. A sufficiently large I-Ca,I-L conductance was needed for P2R to occur, but once above the critical conductance, blocking I-Ca,I-L promoted P2R. However, selectively blocking the window and late components of 1, 081 suppressed P2R, countering the effect of the late I-to, Blocking either the peak or late components of sodium current promoted P2R, with the late sodium current blockade having the larger effect. As expected, increasing other potassium currents potentiated P2R, with ATP-sensitive potassium current exhibiting a larger effect than rapid and slow component of the delayed rectifier potassium current. CONCLUSIONS: The peak I-to promotes type 1 ECG and P2R, whereas the late I-to converts type 1 ECG to type 2 ECG and suppresses P2R. Blocking the peak I-CaL and either the peak or the late sodium current promotes P2R, whereas blocking the window and late I-CaL suppresses P2R. these results provide important insights into the mechanisms of arrhythmogenesis and potential therapeutic targets for treatment of Brugada syndrome. [GRAPHICS] .

Increased Right Ventricular Repolarization Gradients Promote Arrhythmogenesis In A Murine Model Of Brugada Syndrome

Arrhythmic Substrate, Slowed Propagation and Increased Dispersion in Conduction Direction in the Right Ventricular Outflow Tract of Murine Scn5a+/- Hearts

In Vivo Studies of Scn5a+/− Mice Modeling Brugada Syndrome Demonstrate Both Conduction and Repolarization Abnormalities

Atrial Arrhythmogenic Properties In Wild-Type And Scn5a+/- Murine Hearts

Experimental Physiology –research Paper: Atrial Arrhythmogenic Properties in Wild‐type and Scn5a+/− Murine Hearts

Patient-specific Ipsc-Derived Cardiomyocytes Reveal Aberrant Activation of Wnt/β-catenin Signaling in SCN5A-related Brugada Syndrome

Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome

Cellular Basis for the Brugada Syndrome and Other Mechanisms of Arrhythmogenesis Associated with ST-segment Elevation.

Atrial Arrhythmogenesis in Wild-Type and Scn5a+/Δ Murine Hearts Modelling LQT3 Syndrome

Delayed Conduction and Its Implications in Murine Scn5a +/− Hearts: Independent and Interacting Effects of Genotype, Age, and Sex

Why Is Only Type 1 Electrocardiogram Diagnostic of Brugada Syndrome? Mechanistic Insights From Computer Modeling

Frequency distribution analysis of activation times and regional fibrosis in murine Scn5a+/- hearts: the effects of ageing and sex.

Phase 2 Re-Entry Without Ito: Role of Sodium Channel Kinetics in Brugada Syndrome Arrhythmias.

The Relationship Between Conduction Velocity and Atrial Arrhythmogenicity under Conditions of Altered Ca2+Homeostasis in Ryr2-P2328s Murine Hearts

The Age‐dependence of Atrial Arrhythmogenicity in Scn5a+/−murine Hearts Reflects Alterations in Action Potential Propagation and Recovery

Characterization of the Epicardial Substrate for Catheter Ablation of Brugada Syndrome.

Acute Atrial Arrhythmogenicity and Altered Ca2+ Homeostasis in Murine RyR2-P2328S Hearts

In Vivo Mapping of Human Ventricular Fibrillation in Brugada Syndrome: The Role of Repolarization Heterogeneity

Alternans in Genetically Modified Langendorff-Perfused Murine Hearts Modeling Catecholaminergic Polymorphic Ventricular Tachycardia

Novel Therapeutic Strategies for the Management of Ventricular Arrhythmias Associated with the Brugada Syndrome

Cellular and Ionic Mechanisms Responsible for the Brugada Syndrome.